Latest / Decera Clinical Education Oncology Podcast
Optimal Dosing Strategies With Regorafenib and TAS-102 for Patients With Metastatic Colorectal Cancer
In this episode, Kanwal Raghav, MD, and Rachel Riechelmann, MD, PhD, discuss key data supporting contemporary dosing strategies with the later-line treatment options regorafenib and TAS-102 for patients with mCRC, with topics including:
Individualizing therapy
Clinical data and experience informing optimal dosing
Key adverse events
Presenters:
Kanwal Raghav, MD, MBBS
Associate Professor, Gastrointestinal Medical Oncology
The University of Texas MD Anderson Cancer Center
Houston, Texas
Rachel Riechelmann, MD, PhD
Head, Clinical Oncology Department
Medical Oncologist
AC Camargo Cancer Center…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.